BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,051,441 | $1,356,000 | 0.23% |
| X-Square Capital, LLC | 199,791 | $258,000 | 0.15% |
| Nikko Asset Management Americas, Inc. | 2,300,682 | $2,968,000 | 0.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $516,000 | 0.04% |
| Baker Brothers Advisors | 2,677,818 | $3,454,000 | 0.02% |
| SHUFRO ROSE & CO LLC | 129,417 | $167,000 | 0.02% |
| ARK Investment Management | 417,433 | $538,000 | 0.01% |
| ALGERT GLOBAL LLC | 36,806 | $47,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 352,465 | $455,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 66,472 | $86,000 | 0.01% |